Plain-English translation of NCT05315167 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This clinical trial is testing a new oral medication called for people with advanced solid tumors (cancers that have spread or cannot be surgically removed) for which standard treatments have not worked or are not suitable. The study will first determine the safest and most tolerable dose of the medication, then test how well it works at that dose in a larger group of patients.
Many patients with advanced solid cancers run out of effective treatment options. This study exists to see whether this new medication might offer hope for patients whose cancers have resisted standard therapies.
You likely qualify if…
You likely don't qualify if…
You will take the medication by mouth once daily. The study has two phases: first, doctors will gradually increase the dose in small groups of patients to find the safest dose; then, a larger group will take the confirmed safe dose for up to 2 years, as long as the medication is helping and your cancer is not progressing. You will have regular visits for blood tests, imaging scans, and check-ins with your doctor to monitor how you are responding and managing any side effects.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China